Healthcare -
Biotechnology - NASDAQ - CH
$ 40.53
0.571 %
$ 3.46 B
Market Cap
-14.53
P/E
CRSP - STOCK-BASED COMPENSATION
Stock-based Compensation CRSP - CRISPR Therapeutics AG
81 M
LAST VALUE
-11.04%
2 YEAR CAGR
18.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR